Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group by Padwal, R et al.
Consensus DocumentOptimizing observer performance of clinic blood
pressure measurement: a position statement from the
Lancet Commission onHypertension GroupRaj Padwala, Norm R.C. Campbellb, Aletta E. Schuttec, Michael Hecht Olsend,e, Christian Dellesf,
Anthony Etyangg, J. Kennedy Cruickshankh, George Stergioui, Michael K. Rakotzj,
Gregory Wozniakj, Marc G. Jaffek,l, Ivor Benjaminm, Gianfranco Paratin,o, and James E. SharmanpJournal of Hypertension 2019, 37:1737–1745
aDepartment of Medicine, University of Alberta, Edmonton, bDepartment of Medi-
cine, Physiology and Pharmacology and Community Health Sciences, O’Brien Institute
for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary,
Calgary, Alberta, Canada, cHypertension in Africa Research Team (HART), MRC
Research Unit: Hypertension and Cardiovascular Disease, North-West University,
Potchefstroom, South Africa, dDepartment of Internal Medicine, Holbaek Hospital,
Holbaek, eCentre for Individualized Medicine in Arterial Diseases (CIMA), Odense
University Hospital, University of Southern Denmark, Odense, Denmark, fInstitute of
Cardiovascular and Medical Sciences, University of Glasgow, UK, gKEMRI-Wellcome
Trust Research Programme, Kilifi, Kenya, hSchool of Life-Course/Nutritional Sciences,
King’s College, St. Thomas’ & Guy’s Hospitals, London, UK, iHypertension Center
STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third
Department of Medicine, Sotiria Hospital, Athens, Greece, jAmerican Medical Asso-
kHigh blood pressure (BP) is a highly prevalent modifiable
cause of cardiovascular disease, stroke, and death.
Accurate BP measurement is critical, given that a 5-mmHg
measurement error may lead to incorrect hypertension
status classification in 84 million individuals worldwide.
This position statement summarizes procedures for
optimizing observer performance in clinic BP measurement,
with special attention given to low-to-middle-income
settings, where resource limitations, heavy workloads, time
constraints, and lack of electrical power make
measurement more challenging. Many measurement errors
can be minimized by appropriate patient preparation and
standardized techniques. Validated semi-automated/
automated upper arm cuff devices should be used instead
of auscultation to simplify measurement and prevent
observer error. Task sharing, creating a dedicated
measurement workstation, and using semi-automated or
solar-charged devices may help. Ensuring observer training,
and periodic re-training, is critical. Low-cost, easily
accessible certification programs should be considered to
facilitate best BP measurement practice.
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igh blood pressure (BP) is the leading modifiable
risk factor for death and disability in the world,
affecting an estimated 1.4 billion adults globally,
and leading to over 10 million deaths per year [1,2]. It is a
leading cause of heart disease, stroke, and chronic kidney
disease and a major contributor to escalating healthcare
costs [3]. With an overall global adult prevalence of 31%,
high BP is highly prevalent in all major regions of the world
[2]. However, in absolute numbers, it is low-to-middle
income countries (LMICs) that bear the highest burden of
illness, having over one billion individuals affected, and
possessing awareness, treatment and control proportionsJournal of Hypertensionthat lag high-income countries to a considerable degree [2].
Accordingly, ongoing efforts to improve the diagnosis,
prevention, treatment, and control of hypertension globally
must include tailored interventions that prioritize reduc-
tions in regional disparities [4].
Accurate and reliable BPmeasurement is essential for the
proper diagnosis and management of hypertension [5]. On
a population-wide level, a 5-mmHg difference in SBP
corresponds to an estimated 6% absolute and 30% relative
change in hypertension prevalence [6]. Accordingly, the
effect of a 5-mmHg error in BP measurement, assuming a
global prevalence of 1.4 billion [2], could lead to the
incorrect classification of hypertension status in 84 million
individuals worldwide. Therefore, the ramifications of inac-
curate measurement on a global level are profound.www.jhypertension.com 1737
Padwal et al.Blood pressure is a physiological parameter that changes
constantly in response to endogenous factors and exoge-
nous stimuli [7]. This variability makes assessment of ‘usual’
BP, which is defined as an individual’s true or genuine BP,
challenging.BPmeasurement isperhaps themost commonly
performed procedure in clinical medicine and, although, at
first glance, it seems simple, in reality, many steps must be
performed sequentially and optimally in order to produce a
reproducible result reflective of usual BP. Accordingly, the
individual responsible for measuring BP, herein referred to
as the ‘observer’, must be meticulous in terms of following
recommended techniques [8]. The challenges posed by the
variable nature of BPwere recognized over a century ago by
Riva-Rocci et al. [9], who noted that takingmultiplemeasure-
ments and standardizing the measurement conditions could
optimize use of the technique in clinical practice. He con-
cludes, in his seminal paper written in 1896, that ‘. . . if the
procedures are neglected, and the doctor is satisfied with a
crude reading, the method will become useless and will be
quickly abandoned as a scientists’ indulgence’ [9].
Unfortunately, in contemporary clinical practice, BPmea-
surement is often suboptimally performed, and this type of
unstandardized BP measurement leads to errors that can
inappropriately alter management decisions in 20–45% of
cases [10–13]. The problem of unstandardized BP measure-
ment has persisted for decades despite extensive education
and substantial efforts to raise awareness on the adverse
consequences of inaccurate clinic BP measurement [5,14].
Time constraints and suboptimal technique leading topoorly
performed auscultation are responsible formuchof this error
[10,15]. Potential solutions to minimize error, discussed
below, include simplifying the measurement process by
using automated devices and encouraging observers to
undergo certified training and re-training to promote ongo-
ing use of standardized measurement techniques.TABLE 1. Blood pressure measurement methods commonly used in c
Measurement method Comment
Direct (intra-arterial) Commonly used in the critical care setting, where dete
Indirect Commonly used outside of the critical care setting. Upp
Auscultation A good technique, if performed optimally, because SBP
appearance and disappearance of the Korotkoff soun
is a major limitation.
Can be performed using a mercury, aneroid, or electro
aneroid sphygmomanometers contain moving parts t
accuracy over time.
Simultaneous, two-observer, blinded, auscultatory mea
sphygmomanometer and a proper bladder size is the
practice.
Semi-automated or
fully automated
Both approaches typically use the oscillometric techniqu
auscultation or both. Semiautomated devices are not
performed manually (obviating the need for a power
control both inflation and deflation.
An important issue with automated devices is that man
accuracy.
Major advantages of automated BP measurement that
measurement process and elimination of observer-re
the ability to take multiple, sequential, unobserved m
and may require more space and time in the clinical
setting, automated home and ambulatory BP measur
relative to clinic measurements, including detection o
home and ambulatory BP measurement is recommen
A disadvantage is that the oscillometric technique indir
herald the occurrence of systole and diastole exist) a
algorithm makes it difficult to consider oscillometry a
a critically important consideration in automated dev
BP, blood pressure; LMIC, low-to-middle-income countries.
1738 www.jhypertension.comThe aimof the Lancet Commission onHypertensionwas to
identify key actions to improve the global management of BP
both at the population and the individual levels, and to
generate a campaign toadopt thesuggestedactions atnational
levels to reduce the impact of elevated BP globally [4]. The
purpose of this position statement is to provide guidance
towards optimizing observer-related clinic BP measurement
performance for hypertension diagnosis and treatment, with
special attention given to measurement in LMIC settings. We
beginwith abrief reviewof differentmeasurementmodalities,
including adiscussionof optimalmeasurement technique and
the errors that result from deviating from standardized mea-
surement practices. We then outline the impact of observer
training on performance of BP measurement. Subsequently,
we discuss BP measurement in LMIC settings, specifically the
practical considerations that limit achievement of best prac-
tice.We close with recommendations for optimizing observer
accuracy in clinic BP measurement and provide suggestions
on future directions.TYPES OF BLOOD PRESSURE
MEASUREMENT USED IN CLINICAL
PRACTICE ANDOPTIMAL
MEASUREMENT TECHNIQUE
Direct (or intra-arterial) and indirect (cuff-based) BP mea-
surement are the twomajormethods employed in the clinical
care setting and are summarized in Table 1. Indirect mea-
surement is typically performedvia auscultationor byusing a
semi-automatedor fully automated device,whichmost often
uses the oscillometric technique (Table 1). Although there
are definitions in the literature for semi-automated and
automated BP measurements, herein we refer to semi-auto-
mated as those devices that require a manual inflation (e.g.linical practice
cting short-term BP changes is essential.
er arm cuff BP measurement is preferred.
and DBP correspond to distinctly detectable physiological phenomena – the
ds, respectively. However, rarely performed properly in clinical practice, which
nic sphygmomanometer. Mercury has been banned in many jurisdictions and
hat require frequent calibration, which is often not performed, limiting
surement performed according to standardized methods using a mercury
reference standard for BP validation studies but is too impractical for clinical
e, although, rarely, a fully automated device may employ electronic
commonly used but may be advantageous in LMIC settings as inflation is
source). Semiautomated deflation is device-controlled. Fully automated devices
y available on the market have not been properly validated for measurement
make it the preferred technique to use in the clinic include simplification of the
lated errors in auscultation. Automated office BP (AOBP) measurement offers
easurements (reducing white-coat effect), but these devices are relatively costly
visit – further research to define their role is needed. Outside of the clinic
ement modalities provide superior diagnostic and prognostic capabilities
f white-coat and masked hypertension effect. If resources allow, use of AOBP,
ded.
ectly estimates BP (i.e. no discrete ‘oscillometric’ physiological phenomena that
nd is less accurate in some patients. In addition, the proprietary nature of the
s a singular measurement method and makes device (and algorithm) validation
ice selection for clinical use.
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TABLE 2. Essential elements of performing a standardized clinic blood pressure measurement
Element Comment
Device
Use a calibrated (for aneroid devices) or clinically validated (for automated
devices) instrument.
Mercury columns should be at zero when at rest and the mercury column
should be fully intact and readable.
Aneroid devices require regular calibration.
Electronic devices should be validated against two-observer mercury-based
auscultation in an independently performed clinical study using an
internationally accepted protocol. Validated device listings are available at
https://bihsoc.org/bp-monitors and https://hypertension.ca/hypertension-and-
you/managing-hypertension/measuring-blood-pressure/devices/.
Preparation and positioning
Aneroid devices or mercury columns should be clearly visible at eye level.
The patient should be resting comfortably in a quiet environment for 5min
in a chair in the seated position, back-supported, legs uncrossed, feet flat on
the floor, and the arm supported with the BP cuff at heart level.
There should be no talking by the patient or observer during the entire
measurement procedure. The patient should have an empty bladder and not
have eaten, ingested caffeine, smoked, or engaged in physical activity at
least 30min prior to the measurement.
Cuff
Inflatable bladder width should be about 40% of arm circumference and
bladder length should be about 80–100% of arm circumference. For
electronic devices, select cuff size as recommended by the manufacturer.
Using too large a cuff leads to falsely low readings and using too small a cuff,
falsely high readings. Markings on the cuff clearly indicate the ideal arm
circumferences appropriate for the cuff size.
For auscultation, the lower edge of the cuff should be 2–3 cm above the
elbow crease and the bladder should be centered over the brachial artery.
For electronic devices, place the cuff as recommended by the manufacturer.
Procedure
For auscultation, increase the pressure rapidly to 30mmHg above the level
at which the brachial or radial pulse is extinguished, place the stethoscope
head over the brachial artery, deflate the cuff by approximately 2mmHg per
heartbeat, and determine systolic (appearance of Korotkoff sounds) and
diastolic (disappearance of Korotkoff sounds). If the Korotkoff sounds persist
towards zero, use the point of muffling of the sounds to indicate DBP. For
automated devices, initiate the measurement as per the device instructions.
Record the BP to the closest 2mmHg for auscultation or exactly as displayed
on the screen of an automated device. Avoid terminal digit preference
(rounding up or down to a zero or five for the last digit). On the initial visit,
readings should be taken in both arms and the arm with the higher BP
should be used for subsequent measurements. Two or more readings should
be taken at each visit and the mean calculated and used for making clinical
decisions.
Data from [5].
Observer performance in blood pressure measurementwith using bulb compressions). Once inflation has been
completed, these devices typically use an automated defla-
tion process to determine BP. In contrast, fully automated
devices have automated inflation and deflation – the user
initiates ameasurement, usually bypressing abutton, and the
remainder of the inflation–deflation process is automated.
Automated office BP (AOBP) measurement is a subtype of
automated measurement that involves taking sequential
automated measurements rather than a single measurement
at a time. In the oscillometric technique, arterial pulses are
first sensed, filtered, processed and, then, a proprietary
algorithm is applied to estimate BP [16].
BP measurement should be performed carefully by a
trained observer using standardized methodology (Table 2
and Fig. 1; Supplementary Figures S1–S5, http://link-
s.lww.com/HJH/B93) [5]. The mean of multiple research
quality auscultatory and, more recently, automated oscillo-
metric measurements, sometimes taken over two or more
clinical visits,was themethodused toestimate theusualBP in
many foundational prognostic and therapeutic studies in the
fieldof hypertension [17–19].Multiple readings over time are
required to estimate the usual BP, allow for regression to the
mean, and reduce the white-coat effect [20].
CAUSES OF INACCURATE BLOOD
PRESSUREMEASUREMENT IN CLINICAL
PRACTICE
Unfortunately, standardized auscultatory measurement is
not performed commonly in clinical practice [12,21]. It is
also rarely performed by medical trainees [11,22]. Instead,
‘casual’ measurement, in which standardized methodologyJournal of Hypertensionis not followed, is common. Casual measurement typically
leads to higher variability, overestimation of SBP by 5–
10mmHg, and poorer correlation with hypertension related
end-organ damage [10,11,15,23].
Multiple causes of inaccuracy exist and canbe categorized
into patient-related, procedure-related, equipment-related,
or observer-related (Table 3) [24]. Poorly performed auscul-
tation is responsible for much of the error [10,15]. Major
barriers to standardizedBPmeasurement include insufficient
attention paid to optimal technique, lack of observer educa-
tion, competing demands and observer time constraints, and
use of inaccurate equipment [8,14,25]. Common observer-
related errors in the clinical setting include failure to include a
5-min rest period, talking during the measurement proce-
dure, using an incorrect cuff size, and failure to takemultiple
or bilateral measurements [12,23]. Time constraints are a
particularly common reason for casual measurements, as a
casual reading takes about 2min to perform versus 8min for
a standardized measurement [12,26]. Physician readings are
higher than nurse readings, which has been attributed to
incremental white-coat effect [27]. Ultimately, the observer is
responsible for performing a proper measurement and
ensuring to the greatest extent possible that all of the poten-
tial causes of inaccuracy are avoided.
ADVANTAGES OFAUTOMATED BLOOD
PRESSUREMEASUREMENT
Use of automated BP measurement is also supported by
many foundational prognostic and therapeutic studies in the
field of hypertension [17–19]. Its major advantage is that it
reduces observer error by automating the BP measurementwww.jhypertension.com 1739
FIGURE 1 Standardized blood pressure measurement procedure.
Padwal et al.process. Accordingly, less observer expertise is needed,
auscultatory training is not required, and the observer can
focus on mastering a smaller number of essential aspects of
BP measurement [28]. Automated BP could improve BP
measurement technique even further if devices programmed
to take BP in a guideline-concordant fashion were available.1740 www.jhypertension.comExamples include electronically displayed step-by-step
instructions to remind observers of proper technique and
auto-controlled initiation sequences that require a timed rest
period before the first reading is performed.
An additional, and critically important advantage of
automated BP, although beyond the immediate focus ofVolume 37  Number 9  September 2019
TABLE 3. Major sources of error during blood pressure measurement
Source Range of mean error
in SBP (mmHg)
Range of mean error
in DBP (mmHg)
Patient-related
Acute meal ingestion 6 5 to 2
Acute caffeine use þ3 to þ14 þ2 to þ13
Acute nicotine use þ3 to þ25 þ3 to þ18
Bladder distension þ4 to þ33 þ3 to þ19
White-coat effect Up to þ26 Up to þ21
Procedure-related
Insufficient rest þ4 to þ12 þ2 to þ4
Legs crossed at knees þ3 to þ15 þ1 to þ11
Arm lower than heart level þ4 to þ23 þ3 to þ12
Talking during measurement þ4 to þ19 þ5 to þ14
Fast deflation rate 9 to 3 þ2 to þ6
Equipment-related
Automated device variabilitya 4 to þ17 8 to þ10
Too small a cuff þ2 to þ11 þ2 to þ7
Too large a cuff 4 to 1 5 to 1
Observer-related
Terminal digit preference for zero (rounding off
during auscultatory measurements)
Up to 79% over-representation
of terminal zero
Up to 79% over-representation
of terminal zero
Reliance on a single measurement þ3 to þ10 2 to þ1
Hearing deficit 2 to 0.1 þ1 to þ4
Data from [24].
aTo optimize automated device accuracy, use a validated device.
Observer performance in blood pressure measurementthis position paper, is that it enables many measurements to
be taken in the out-of-clinic setting in the usual environ-
ment of each individual. Out-of-clinic measurement
includes 24-h ambulatory monitoring and home BP moni-
toring and leads to much better assessment of usual BP
because, in addition to eliminating observer error, it elim-
inates white-coat (high clinic but normal out-of-office BP)
and detects masked hypertension (normal clinic but high
out-of-office BP) phenomena. Indeed because of the exis-
tence of white-coat, andmasked hypertension effect, which
affect 9–24 and 9–17% of untreated and treated individuals,
respectively, even meticulously performed standardized
office BP may not be representative of usual BP [29].
Contemporary guidelines recommend confirming the diag-
nosis of hypertension with out-of-office BP measurements
and treating masked, but not white-coat, hypertension [30].
Twenty-four-hour ambulatory and home BP monitoring
are far superior to clinic measurements in terms of their ability
to predict cardiovascular events [31,32]. 24-h BPmonitoring is
the gold standard for diagnosing hypertension and home BP
monitoring is ideal for performing long-term follow-upmoni-
toring of treated hypertensive patients, especially when cou-
pled with nurse or pharmacist case management [33–36]. If
resources allow, use of both of thesemeasurementmethods is
highly recommended [30,35,37,38]. Both out-of-clinic mea-
surementmodalities requireproper technique, andhealthcare
professionals must understand that home BP monitoring
requires patient training in order to be effective in improving
clinical decisions [33,36,39].
As mentioned above, AOBP offers the ability to perform
three to five unattended, sequential BP measurements and
auto-calculate the mean [40]. AOBP is a subtype of fully
automated BP measurement; the critical distinction is that
sequential readings are automated. Practically, this means
the observer is required to initiate only the first reading of
the sequence; she or he can then leave and return when theJournal of Hypertensionentire sequence is finished (as opposed to remaining in the
room to initiate each sequential measurement). Use of
AOBP, particularly when performed when the patient is
alone in the room, facilitates a more standardized measure-
ment process (e.g. no talking, multiple automated measure-
ments taken sequentially). Consequently, the AOBP
technique is associated with reduced white-coat effect
[40,41,42–44]. AOBP requires additional space and time
and the cost of AOBP devices is also 5-fold to 10-fold higher
than regular automated (home) devices, which also limits
use in the LMIC setting. However, if these barriers are not
present, use of AOBP should be considered to enable
greater standardization of in-clinic BP measurements.
Some automated devices have been specifically
designed for use in the LMIC setting [45–47].
AUTOMATED DEVICE ACCURACY
An important issue with automated devices is that many
have not been clinically validated for measurement accu-
racy [48]. Clinical validation involves demonstrating that the
device meets the accuracy requirements of international BP
measurement standards [49]. This process involves per-
forming a protocol-based comparison using multiple meas-
urements against a blinded, two-observer auscultatory
reference standard. To maximize accuracy, only validated
devices should be used in clinical practice [50].
In some individuals, even validated devices may pro-
duce BP measurements that differ substantially from aus-
cultation; this may result from variations in algorithm
performance and/or arterial wall properties [51,52]. For this
reason, it is desirable to ensure that a specific device is
performing well in a specific patient. Unfortunately, there is
no consensus on how to do this in an efficient and feasible
manner that is applicable in clinical practice. This issue is
discussed in further detail elsewhere [53,54].www.jhypertension.com 1741
Padwal et al.OBSERVERTRAININGTO IMPROVE
CLINIC BLOOD PRESSURE
MEASUREMENT
Observer training has been proposed as a solution to poor
measurement technique. Training programs leading to short-
term success in improving measurement technique have
been described, all emphasizing the fundamentals of proper
BP measurement (Table 2), and varying in their delivery
format, from web-based to in-person, and in length, from
30 min to full-day sessions [55–57]. Clearly, shorter, web-based
programs are preferred because of their practical advantages,
lower cost and scalability. Beyond observer training alone,
bundled quality improvement programs that combine use of
automated office BP measurement with provider education
on proper measurement and advice on clinical workflow
improvement have been examined and shown to increase
use of automated measurement and reduce terminal digit
preference [58]. Additional approaches that have been pro-
posed include training patients to recognize when their care
providers are performing improper measurement and having
regulatory agencies enforce use of standardizedmeasurement,
but the practical implementability of these propositions is
uncertain [59,60].
A trained nurse with auscultatory expertise can approxi-
mate daytime ambulatory BP, a commonly used reference
standard, better than automated devices [61]. However, the
generalizability of this finding to an observer with less
expertise undergoing a single training seminar, in the LMIC
setting or otherwise, is likely to be low. Auscultation
appears to be particularly difficult to perform in a uniform
manner over time. The inter-observer variability of auscul-
tatory BP measurements between expert observers was
minimized by repeated training sessions, validating the
importance of retraining [62]. However, following each
training session, between-observer variability increased
after just 1–2 months, indicating that very frequent re-
training is required to maintain auscultatory skills. These
data indicate that training requirements are greater over theTABLE 4. Challenges to and potential solutions for optimizing clinic b
Challenges
Lack of prioritization of and funding for hypertension care and proper BP
measurement, including provider reimbursement, programmatic funding,
and equipment.
Limited observer education and training in standardized BP measurement.
High provider workload and limited time to perform proper measurement,
including between-patient cuff changes. Lack of dedicated clinic space to
perform BP measurements.
Lack of availability of inexpensive, easily operable, clinically validated
automated BP devices necessitating use of auscultation.
Lack of availability of BP device accessories, including batteries and additional
cuffs. Lack of proper environmentally responsible battery disposal
mechanisms. Limited and/or lack of access to electrical power.
Extremely high environmental temperatures in some regions that may
theoretically affect the performance of BP devices.
BP, blood pressure.
1742 www.jhypertension.comshort-term and long-term if the auscultatory technique is
used, which is not feasible for widespread implementation,
particularly in the LMIC setting. Accordingly, use of auto-
mated devices is recommended to minimize additional
training requirements.
Overall, training improves BP measurement practices
over the short term and retraining is required to maintain
skills over the long term. The optimal frequency of retrain-
ing is unclear. As a practical compromise, to avoid a
burdensome retraining schedule yet ensure relatively fre-
quent refreshment of skills, retraining is recommended at
least annually.
ADDITIONAL CHALLENGES TO
OPTIMIZING CLINIC BLOOD PRESSURE
MEASUREMENT IN THE LOW-TO-
MIDDLE-INCOME SETTING
Additional challenges exist in LMIC settings and many are
not easily solved. These are summarized in Table 4,
together with proposed solutions.RECOMMENDATIONS FOROPTIMIZING
OBSERVER PERFORMANCE IN BLOOD
PRESSUREMEASUREMENTAND FOR
STAKEHOLDER IMPLEMENTATION
Recommendations for optimizing observer performance in
BPmeasurement and stakeholder implementation are listed
in Fig. 2 and focus on performing simplified, standardized
measurements using validated semi-automated or auto-
mated devices in a properly configured setting, and ensur-
ing proper observer training and periodic retraining. Task-
sharing by training nonphysician healthcare or lay pro-
viders, such as nurses and community health workers to
perform measurement, is strongly advised because it frees
physicians, who are in short supply relative to other health-
care providers, to perform other work and also reduceslood pressure measurement in the low-to-middle-income setting
Proposed solution
Increased advocacy and recognition of the importance and scope of the
problem.
Training that is easily accessible and affordable. Eliminate the need for
expertise in auscultation, and errors resulting from poorly performed
auscultation, by using semi-automated or fully automated devices.
Simplify measurement practices by modifying workplace ergonomics to
facilitate best measurement practices (e.g. have a dedicated BP
measurement station including a chair with arm-rest, even if not in a
segregated clinical space, and arrange furniture to optimize patient and
observer position).
Increased advocacy and awareness of the need for clinical validation and low-
cost devices. Encourage manufacturers to market low-cost clinic, home, and
ambulatory devices.
Choose validated semi-automated or solar-charged device overcome
requirements for batteries or electrical power. A reasonable compromise if
only one cuff size is available is to choose the cuff size that is considered
optimal for most of the patients seen in that clinical setting.
Requires further study.
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Recommendaons
Conﬁgure sengs for BP measurement to ensure use of 
standardized measurement pracces.
Use task sharing (training non-physician health care or lay 
providers) to perform BP measurement.
Ensure proper observer training, preferably with 
cerﬁcaon, and refresh training annually.
Perform BP measurement using recommended, 
standardized technique. Use cuﬀs properly sized to arm 
circumference.  If mulple cuﬀ sizes are unavailable, use 
the cuﬀ size opmal for most of the populaon.
Use validated upper-arm cuﬀ semi-automated or 
automated devices instead of auscultaon to reduce the 
need for training and opmize BP measurement. 
Use validated semi-automated or solar-charged devices if 
resources constrain use of baery-operated or electrically 
operated automated devices.
Governments and 
Regulatory Agencies
• Require provider 
training and 
cerﬁcaon 
standards
Clinics and Providers
• Require provider 
training and 
cerﬁcaon
• Ensure adherence to 
standards
Journals
• Require proper 
reporng and accept 
only studies that 
used standardized 
measurement
Manufacturers
• Advocate for 
standardized 
measurement
• Include standardized 
measurement 
instrucons with 
device for sale
Professional Sociees 
and NGOs
• Develop and 
implement training 
and cerﬁcaon 
standards
• Advocate for such 
programs
• Accredit exisng 
training programs
FIGURE 2 Recommendations for optimizing observer performance in clinic blood pressure measurement and for stakeholder implementation.
Observer performance in blood pressure measurementwhite-coat effect [27,63,64]. Task shifting alone may not
improve BP control if clinics are overburdened, equipment
is unreliable, or antihypertensive therapy is unavailable
[65]. The core curricula of healthcare professional schools
and postgraduate training programs should include stan-
dardized training and performance testing in blood
pressure measurement.
FUTURE DIRECTIONS
Given the importance of proper observer training, pro-
grams are needed to assist observers in acquiring the
necessary skills to perform proper BP measurement. To
this end, training courses that provide certification in stan-
dardized measurement, endorsed by prominent national
and international organizations working in the field, would
encourage and substantiate best measurement practices.
The World Hypertension League has developed resources
to assist providers to perform BP screening [66]. Proper BP
measurement Certification programs should not be onerous
and need to be simple, brief, multilingual, low-cost (ideally,
free), easily repeatable and widely accessible. Research is
needed to identify the best methods of delivering training,
and further work is required to identify how and where
training and certification could be best performed and if
certification should be required.CONCLUSION
Given the enormous, and increasing, global burden of
hypertension, the need to improve all aspects of preven-
tion, detection, treatment and control is clear [4]. The
importance of proper BP measurement to optimal hyper-
tension diagnosis and management cannot be overempha-
sized. Much of the error in BP measurement is within
the control of the observer. Therefore, simplifying,Journal of Hypertensionstandardizing, and automating measurement practices
and ensuring proper observer education, training and cer-
tification is needed. Even these relatively straightforward
recommendations can be challenging to implement, but
they have the potential to markedly improve detection and
management of hypertension across the world. Given the
importance of accurate BP assessment, and the lack of
impact of previous efforts to train healthcare workers,
consideration should be given to regular certification in
BP assessment.
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